the pharmacokinetics of oral amiodarone support the practice of using high loading dosages until arrhythmia suppression or apparent steady state is achieved ( usually 2-4 weeks ) , followed by low-dose maintenance therapy ( 200-600 mg once a day ) for treatment of symptomatic atrial and ventricular tachyarrhythmias .
C0002598
amiodarone
C0003811
arrhythmia